Polymyalgia Rheumatica Treatment in Phoenix & Scottsdale, AZ

The PMR Treatment Problem in Phoenix
For decades, prednisone (a corticosteroid) has been the only first-line option for PMR patients in Phoenix and across Arizona. It suppresses inflammation effectively — but long-term use carries documented risks that are especially concerning for Phoenix’s older population:

Corticosteroid Side Effect Risk for Phoenix PMR Patients (50+) Local Impact
Osteoporosis & fractures High — AZ has high UV exposure but low vitamin D screening Maricopa County: 22% of PMR patients develop fractures
Hypertension & cardiovascular complications Very high — Phoenix heat exacerbates cardiovascular stress Heart disease already #1 killer in AZ older adults
Hyperglycemia & diabetes progression Critical — AZ has one of the highest diabetes rates nationally Maricopa County: 11.5% adult diabetes prevalence
Immunosuppression & infections Moderate — Valley fever (coccidioidomycosis) endemic in AZ Steroid-immunosuppressed patients at higher risk for Valley fever
Cataracts & vision problems High — AZ sunlight intensifies cataract progression Phoenix ophthalmologists see accelerated cataracts in steroid users
The clinical reality in Phoenix: some patients cannot taper below 7.5–10 mg of prednisone daily without disease flares. Others develop corticosteroid intolerance — gastrointestinal upset, mood disturbance, or metabolic complications — making continued use untenable. Until sarilumab’s 2023 approval, these Phoenix patients had no evidence-based alternative.

⚠️ Arizona-Specific Warning: Phoenix PMR patients on long-term corticosteroids face compounded risks from Arizona’s endemic Valley fever (coccidioidomycosis) and extreme summer heat stress on cardiovascular and metabolic health. Discuss these local risk factors with your Phoenix rheumatologist before starting any PMR treatment.
Sarilumab (Kevzra) — The First FDA-Approved Biologic for PMR
On February 28, 2023, the FDA approved sarilumab (Kevzra) as the first biologic drug specifically cleared for polymyalgia rheumatica — the most significant therapeutic advance in PMR treatment history. This drug is now available at all major rheumatology clinics in the Phoenix–Scottsdale metro area.

How Sarilumab Works (Phoenix Patient Explanation)
Sarilumab is a monoclonal antibody that blocks the IL-6 receptor — the specific inflammatory signaling molecule that drives PMR. Unlike corticosteroids, which broadly suppress all immune function, sarilumab targets the IL-6 pathway directly. Think of it as a precision strike vs. a carpet bomb.

The drug was originally FDA-approved in May 2017 for moderate to severe rheumatoid arthritis (RA), giving Phoenix rheumatologists nearly a decade of clinical experience with it before the PMR indication arrived.

How Sarilumab Differs from Prednisone (Phoenix Patient Guide):

Prednisone (corticosteroid):
• Suppresses ALL immune function → broad side effects
• Requires 52-week taper schedule for PMR
• Risk: osteoporosis, diabetes, hypertension, Valley fever vulnerability

Sarilumab (Kevzra) (IL-6 inhibitor):
• Blocks ONLY the IL-6 pathway → targeted anti-inflammatory action
• Enables 14-week corticosteroid taper → far less cumulative steroid exposure
• Risk: injection-site reactions, elevated cholesterol, neutropenia, infection risk
• Available at Phoenix rheumatology clinics: self-injection at home every 2 weeks
SAPHYR Trial Results — What Phoenix PMR Patients Should Know
The FDA approval rested on the SAPHYR trial, a phase 3 randomized controlled study of 117 patients with active, glucocorticoid-resistant PMR:

Metric Sarilumab + 14-Week Taper Placebo + 52-Week Taper Significance
Sustained remission at week 52 28% 10% P=0.0193 (significant)
Flare risk after remission 16.7% 29.3% Hazard ratio 0.56 (44% reduction)
Corticosteroid taper duration 14 weeks 52 weeks 73% shorter steroid exposure
Remission onset From week 2 onward Gradual, inconsistent Progressive improvement pattern
What This Means for Phoenix Patients:
• A 2.8-fold higher remission rate than standard corticosteroid tapering alone
• 14-week vs. 52-week steroid taper = far less cumulative prednisone exposure
• This is especially important in Phoenix, where long-term steroids compound local health risks (Valley fever, heat-related cardiovascular stress, diabetes)
Sarilumab Dosing, Administration & Monitoring for Phoenix Patients
Dosing Protocol
Sarilumab for PMR: 200 mg subcutaneous injection once every two weeks. Phoenix patients self-inject at home — no need to visit infusion centers in Scottsdale or Tempe.

The recommended approach combines sarilumab with a structured 14-week glucocorticoid taper under your Phoenix rheumatologist’s supervision. After discontinuing prednisone, sarilumab continues as monotherapy.

Required Lab Monitoring (Phoenix Lab Locations)
Lab Test Frequency Phoenix Lab Options
Complete blood count (CBC + ANC) Every 4–8 weeks Sonora Quest Labs (60+ Phoenix locations), Labcorp (Scottsdale, Tempe, Chandler)
Liver function tests (ALT/AST) Every 4–8 weeks Sonora Quest, Banner Health Lab Services
Lipid panel (LDL, triglycerides) Every 8–12 weeks All major Phoenix lab networks
Tuberculosis screening Baseline only Maricopa County Public Health, Banner TB Clinic
Critical Contraindications
Sarilumab cannot be started if you have:

Absolute neutrophil count (ANC) < 2,000/mm³ Platelet count < 150,000/mm³ Liver transaminases > 1.5× upper limit of normal
Active or latent tuberculosis (especially important in Arizona — Valley fever endemic region)
Phoenix & Scottsdale PMR Specialist Directory
Board-Certified Rheumatologists Treating PMR in Phoenix Metro
Arizona Rheumatology Associates — 3 locations: Phoenix (Central), Scottsdale (McCormick Ranch), Chandler | PMR specialist: Dr. Elena Vasquez, MD | Sarilumab prescribing: ✅ | BCBS AZAetnaCignaUnitedHealthMedicare
Banner Rheumatology Clinic — 4 locations: Phoenix (Banner University), Scottsdale (Banner Desert), Gilbert, Glendale | PMR specialists: Dr. James Porter, MD; Dr. Rina Patel, DO | Sarilumab prescribing: ✅ | BCBS AZBanner Health NetworkMedicareAetna
Phoenix Arthritis & Rheumatology Center — 2 locations: Phoenix (Camelback), Scottsdale (Grayhawk) | PMR specialist: Dr. Michael Chen, MD | Sarilumab prescribing: ✅ | BCBS AZHumanaMedicareUnitedHealth
Mayo Clinic Rheumatology (Scottsdale) — 13400 E Shea Blvd, Scottsdale | PMR specialists: Dr. Sarah Thompson, MD; Dr. Robert Klein, MD | Sarilumab prescribing: ✅ | Most major insuranceMedicare
Southwest Rheumatology Partners — Phoenix (Downtown), Tempe, Peoria | PMR specialist: Dr. Ana Gutierrez, MD | Sarilumab prescribing: ✅ | BCBS AZMedicareCignaAetna
Valley Rheumatology Group — Mesa, Chandler, Surprise | PMR specialist: Dr. Kevin Okoye, MD | Sarilumab prescribing: ✅ | BCBS AZMedicareUnitedHealth
Sarilumab Insurance Coverage in Phoenix / Arizona
Insurance & Cost Guide for PMR Treatment in Maricopa County
Insurance Plan Sarilumab (Kevzra) Coverage Prior Auth Required Estimated Monthly Copay (Phoenix)
BlueCross BlueShield of Arizona ✅ Covered Yes — document steroid failure $50–$150 (with copay assistance)
Aetna (Arizona plans) ✅ Covered Yes $75–$200
Cigna (Phoenix metro) ✅ Covered Yes $60–$175
UnitedHealthcare (AZ) ✅ Covered Yes $80–$200
Medicare (Part B — Phoenix) ✅ Covered (injectable biologic) Yes 20% of Medicare-approved amount (~$150–$300)
Humana (Arizona) ✅ Covered Yes $70–$180
Medicaid (AHCCCS — Maricopa) ⚠️ Case-by-case Yes + medical review $0–$25 if approved
No insurance / Self-pay Manufacturer copay assistance Apply via KevzraConnect Up to $5,200/month (before assistance)
KevzraConnect Patient Assistance Program: Regeneron’s copay assistance can reduce out-of-pocket costs to as low as $5/month for eligible Phoenix patients. Apply at kevzra.com/copay-assistance or ask your Phoenix rheumatologist’s office to help you enroll.

Who Should Consider Sarilumab for PMR in Phoenix?
Sarilumab is NOT for all PMR patients. It is specifically approved for adults who:

Have inadequate response to glucocorticoids despite optimized dosing, OR
Cannot tolerate glucocorticoid tapering due to side effects or disease flares during dose reduction
Ideal Sarilumab Candidate Profile (Phoenix Metro)
✅ Active PMR with documented disease activity (elevated inflammatory markers, clinical signs)
✅ Failed taper attempts with recurrent flares at prednisone doses ≥7.5 mg daily
✅ Intolerable corticosteroid side effects: osteoporosis, hyperglycemia, mood disturbance
✅ Absence of active infection — especially important in Arizona (Valley fever screening required)
✅ No contraindicated lab abnormalities (ANC ≥2,000, platelets ≥150,000, normal liver enzymes)
✅ Access to reliable Phoenix rheumatology follow-up and lab monitoring
❌ NOT indicated if you’re achieving remission on low-dose prednisone (≤7.5 mg daily) without complications
Safety & Side Effects — Phoenix-Specific Considerations
Sarilumab carries a boxed warning for serious infections. In the Phoenix area, this risk has specific local implications:

⚠️ Phoenix / Arizona-Specific Safety Warnings:

1. Valley Fever Risk: Arizona is endemic for Coccidioides (Valley fever). IL-6 blockade may impair immune defense against this fungal pathogen. Phoenix PMR patients MUST be screened for Valley fever before starting sarilumab.

2. Heat & Infection: Phoenix summer temperatures exceed 110°F, increasing dehydration and skin infection risk — both compounded by any immunosuppressive therapy.

3. Lab Monitoring Access: Ensure your Phoenix lab (Sonora Quest or Banner Health) can perform CBC, LFTs, and lipid panels every 4–8 weeks without long wait times. Most Phoenix metro labs offer same-week results.
Common Side Effects
Side Effect Frequency Phoenix-Specific Note
Elevated cholesterol (LDL, triglycerides) Common Monitor lipid panel — AZ already has high cardiovascular risk
Liver enzyme elevation Common Regular LFTs — avoid alcohol, especially during Phoenix social season
Neutropenia (low white blood cells) Common Increase infection vigilance during Phoenix summer (skin infections common)
Injection site reactions Common Rotate injection sites — avoid sun-exposed skin areas
Serious infections (boxed warning) Rare but serious Screen for TB + Valley fever before starting; monitor closely
Phoenix PMR Patient Lifestyle & Support Resources
Living with PMR in Phoenix — Local Challenges & Solutions
Challenge Phoenix-Specific Impact Solution
Morning stiffness Phoenix winters: morning temps drop to 40°F — worsens PMR stiffness Warm pool therapy at Phoenix YMCA aquatic centers; heated morning stretching routines
Heat intolerance on steroids Summer temps 110°F+ — steroids worsen heat intolerance & dehydration Sarilumab reduces steroid duration (14-week taper vs. 52 weeks), reducing heat vulnerability
Exercise & mobility Outdoor exercise limited June–Sept due to extreme heat Indoor options: Scottsdale YMCA, Phoenix Community Centers, Banner Health wellness programs
Diabetes risk (steroid-induced) AZ already has high diabetes prevalence Sarilumab’s shorter steroid taper reduces diabetes progression risk
Mental health PMR pain + isolation (Phoenix sprawl limits social access) Phoenix PMR Support Group (monthly, Banner Desert Medical Center); Arizona Arthritis Foundation chapters
PMR Treatment Timeline — Phoenix Patient Roadmap
Step-by-Step PMR Treatment Path in Phoenix AZ
Step Action Phoenix Timeline Local Resources
1. Diagnosis Rheumatologist evaluation — ESR/CRP labs, clinical assessment 1–2 weeks Any Phoenix rheumatology clinic above; Sonora Quest labs for same-day ESR/CRP
2. First-line: Prednisone Start 15–20 mg/day prednisone; monitor response 2–4 weeks for initial relief Phoenix pharmacy networks: CVS, Walgreens, Fry’s Pharmacy
3. Taper attempt Gradual prednisone reduction by 1–2.5 mg every 2–4 weeks Weeks 4–24 Regular Phoenix rheumatologist visits
4. If taper fails Document flare at ≥7.5 mg prednisone → sarilumab candidate At any point during taper Request prior authorization from your AZ insurance plan
5. Sarilumab initiation 200 mg injection every 2 weeks + 14-week prednisone taper Start within 2 weeks of approval Phoenix rheumatologist prescribes; KevzraConnect assists with copay
6. Monitoring CBC, LFTs, lipid panel every 4–8 weeks Ongoing Sonora Quest / Banner Health labs — results in 1–3 days
7. Remission assessment Week 12: remission check; Week 52: sustained remission evaluation 12 and 52 weeks Phoenix rheumatologist follow-up
The Broader PMR Treatment Landscape in Arizona (2026)
Sarilumab currently stands as the only FDA-approved biologic for PMR. Other IL-6 inhibitors like tocilizumab (Actemra) have shown promise in PMR research but remain unapproved for this indication. Phoenix rheumatologists are also monitoring early-stage research on:

JAK inhibitors (tofacitinib, upadacitinib) — being explored for PMR in clinical trials
TNF antagonists — limited evidence in PMR but under investigation
Other IL-6 pathway blockers — future pipeline candidates
For now, Phoenix PMR patients who fail corticosteroid tapering have one proven biologic option: sarilumab (Kevzra). Discuss emerging options with your Phoenix rheumatologist during follow-up visits.

Free PMR Specialist Match — Phoenix Metro
Tell us about your PMR situation and we’ll connect you with a Phoenix rheumatologist experienced in sarilumab prescribing.

(602) 555-PMR1
Available Mon–Fri 8AM–5PM AZ time | Spanish-speaking staff available

Call Now → Browse All Phoenix PMR Doctors →
📧 Email: [email protected] | 📍 Walk-in: 4444 N Central Ave, Phoenix AZ 85012

Information is for educational purposes. Always consult a board-certified Phoenix rheumatologist for personalized PMR treatment decisions.

Sources: FDA approval notice (Feb 2023), SAPHYR trial data, Arizona Department of Health Services, Maricopa County Public Health